Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Silicon Phthalocyanine Pc4 for Photodynamic Therapy of Cutaneous T-cell Lymphoma: Single and Repeated Photoexposures

NCT01800838 is registered in ClinicalTrials.gov with Kevin Cooper MD as lead sponsor.

NCT NCT01800838
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01800838 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Silicon Phthalocyanine Pc4 for Photodynamic Therapy of Cutaneous T-cell Lymphoma: Single and Repeated Photoexposures
Lead sponsor
Kevin Cooper MD
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2013
Completion date
May 31, 2015
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent cutaneous t-cell non-hodgkin lymphoma, recurrent mycosis fungoides/sezary syndrome, stage i cutaneous t-cell non-hodgkin lymphoma, stage ia mycosis fungoides/sezary syndrome, stage ib mycosis fungoides/sezary syndrome, stage ii cutaneous t-cell non-hodgkin lymphoma, stage iia mycosis fungoides/sezary syndrome